1%

Question 1 of 60

In the UK programme the following patient groups should not be routinely advised to receive HPV vaccine:

Rationale:
Patients who are pregnant should not be routinely advised to receive the HPV vaccine in the UK programme. This guidance is based on the need to ensure maternal and fetal safety during pregnancy, as the effects of the vaccine in this group have not been sufficiently studied. A: Patients with immunosuppression Vaccination is typically advised for this group to help protect against HPV-related diseases due to their heightened risk of complications. B: Patients with HIV infection Those with HIV are often recommended to receive the HPV vaccine, as they are at increased risk of HPV-related health issues, enhancing their protection. D: Males aged 11-18 years This demographic is included in vaccination recommendations to reduce HPV transmission and associated health risks, making vaccination beneficial for their protection.